Alprostadil (GlobeStar Therapeutics)

N/A

Report date: 2022/12/16 14:36:25

Base Information

Drug NameAlprostadil (GlobeStar Therapeutics)
Drug Alias NameLiposomal prostaglandin E-1Liprostin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP1 receptor agonists
TargetsProstanoid EP1 receptor
Therapy Area/IndicationsPeripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEndovascMiv Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndovasc
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A